Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
US7119186B2 · kind B2 · utility
4Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 1, 2002 |
| Grant date | Oct 10, 2006 |
| Priority date | — |
| Expiry date | Apr 22, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides polynucleotides and proteins, which are involved in early-onset spinocerebellar ataxia with ocular motor apraxia and hypoalbuminemia (EAOH); and methods of using the polynucleotides and/or proteins to treat and/or diagnose EAOH.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.